Clinical Trial Update: Thoratec HeartMate II Left Ventricular Assist System (LVAS) for Destination Therapy [NA]

View source ↗

Summary

A completed clinical trial update for the Thoratec HeartMate II LVAD used for destination therapy in heart failure patients; results were posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiomyopathy
• Heart Failure
• Ventricular Dysfunction

Drugs mentioned

• HeartMate II Left Ventricular Assist System (Left Ventricular Assist System)

Snippet

Sponsor: Abbott Medical Devices | Conditions: Heart Failure, Congestive, Ventricular Dysfunction | NA | Status: COMPLETED | Results posted: 2013-10-29